Skip to Main Content

Paper Details

SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance.
Elife
8
2021
Author NameAffiliation
Richard M WhiteMemorial Sloan Kettering Cancer Center and Weill-Cornell Medical College
  • 1 - 1

Datasets

Release 1.2